Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530686 · ClinicalTrials.gov registry record · Phase 1
Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
A Phase 1 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00530686: Completed Phase 1 study, sponsored by Baylor Research Institute.
NCT00530686 is a Phase 1 study that has completed, run by Baylor Research Institute. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530686, a Phase 1 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to assess a novel approach to immunosuppression in allogenic pancreatic islet cell transplant recipients. In addition, the study aims to assess remote site islet processing with culture for pancreatic islet cell transplantation in human subjects.
Interventions
- DRUG Islet cell transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 1 |
What the finished NCT00530686 record still lists
NCT00530686 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Islet cell transplantation is the first listed.
NCT00530686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00530686 about?
NCT00530686 is a clinical study titled "Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment". The purpose of this study is to assess a novel approach to immunosuppression in allogenic pancreatic islet cell transplant recipients. In addition, the study aims to assess remote site islet processing with culture for pancreatic islet cell transplantation in human subjects.
What is the current status of trial NCT00530686?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2008-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT00530686?
The interventions under investigation include: Islet cell transplantation (DRUG).
Who is sponsoring clinical trial NCT00530686?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00530686's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia